-
Updates- GrouponLive, Softbank, Volkswagen, Wal-Mart, Toshiba, AAPL, GOOG, LYV, WMT, DYN, MCD, UAL
Monday, May 9, 2011 - 8:54am | 1894According to the BrandZ Top 100 ranking, Apple Inc., (NASDAQ:AAPL), designs, manufactures and markets a range of personal computers has overtaken Google Inc. (NASDAQ:GOOG) as the world's most valuable brand. Apple with a stock market capitalization of $319.4 billion, compared with Google's $172....
-
Rosetta Genomics Announces Issuance of Additional U.S. Patent (ROSG)
Monday, May 9, 2011 - 8:35am | 100Rosetta Genomics (NASDAQ: ROSG) today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,943,745, which is related to human hsa-miR-497 and its variants and covers the composition of matter. Human hsa-miR-497 is an important component of the Company's...
-
Benzinga's Top Pre-Market NASDAQ Gainers (ONTY, BSFT, MNKD, SQNM)
Monday, May 9, 2011 - 8:20am | 131Oncothyreon Inc (NASDAQ: ONTY) shares surged 11.63% to $4.99 in the pre-market session. ONTY reported its Q1 net loss from operations at $5.9 million, versus $5.4 million, in the year-ago quarter. BroadSoft Inc (NASDAQ: BSFT) shares advanced 8.31% to $46.77 in the pre-market session. BSFT reported...
-
Benzinga's Top Upgrades (LUV, CCIH, INFI, SPRD)
Monday, May 9, 2011 - 8:19am | 140Dahlman Rose upgraded Southwest Airlines Company (NYSE: LUV) from “hold” to “buy.” LUV's shares closed at $12.11 on Friday. Southwest Airlines' trailing-twelve-month revenue is $12.58 billion. Deutsche Bank upgraded ChinaCache International Holdings Ltd (NASDAQ: CCIH) from “hold” to “buy.” CCIH's...
-
Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera, Says 880,139 Celera Shares Tendered (CRA, DGX)
Monday, May 9, 2011 - 8:14am | 254Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary, has extended the cash tender offer for all outstanding shares of common stock of Celera...
-
Chelsea Therapeutics Announces Approval to Open Enrollment Into 3.0 mg Arms of CH-4051 Phase II Trial in Rheumatoid Arthritis (CHTP)
Monday, May 9, 2011 - 8:01am | 178Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) announced that an independent Data Safety Monitoring Board recently met to review patient safety data for Chelsea's Phase II trial of CH-4051 in rheumatoid arthritis and recommended that each on-going arm of the study continue as planned and...
-
Jefferies Comments On Exact Sciences DDW
Monday, May 9, 2011 - 7:32am | 130According to Jefferies, Exact Sciences (NASDAQ: EXAS) collaborator Dr. David Ahlquist of the Mayo Clinic presented initial data from the first head-to-head pilot study comparing EXAS' Cologuard stool-based DNA (sDNA) test with ARUP Labs' blood-based Septin9 assay. Jefferies said that the study,...
-
Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study (INHX, PFE)
Monday, May 9, 2011 - 7:22am | 135Inhibitex (Nasdaq: INHX), announced today that Pfizer Inc. (NYSE: PFE) presented safety and immunogenicity data from a Phase 1 double-blind randomized placebo controlled study in 408 healthy volunteers of a novel three antigen Staphylococcus aureus investigational vaccine (SA3Ag) at the 21^st...
-
Piper Jaffray Raises INFI Target From $6 To $9, Upgrades Shares To OW
Monday, May 9, 2011 - 7:22am | 34Piper Jaffray is upgrading shares of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) from Neutral to Overweight while raising its PT from $6 to $9. Infinity Pharmaceuticals closed Friday at $5.79.
-
Vertex may be an Acquisition Target, Goldman Sachs Says -Bloomberg (VRTX, GS)
Monday, May 9, 2011 - 7:20am | 31Bloomberg reports that Goldman Sachs (NYSE: GS) recommends buying Vertex (NASDAQ: VRTX) July $55 call options.
-
Market updates: Greece, Chubu Electric, Munich Re, BARC, LLOY, CNA, TCG, ISAT, SRP, ELN, ALKS, VITA, BHP, HBC, LMI
Monday, May 9, 2011 - 6:08am | 1964BHP Billiton Limited (NYSE:BHP) is trading at a price of $95.50, says company and Australia poised to reap benefits of rebalancing of economic weight to Asia; but short to medium-term challenges remain. BHP Billiton Ltd Chairman Jacques Nasser said Monday he believes in a “go-slow” approach to...
-
McGraw-Hill Ryerson Limited Announces Special Dividend of $5; Quarterly Dividend of $0.285/Share
Friday, May 6, 2011 - 4:02pm | 116McGraw-Hill Ryerson Limited (TSX: MHR) announces a quarterly dividend of 28.5 cents per common share has been declared payable on June 2, 2011, to shareholders of record at the close of business on May 12, 2011. This is an increase over the previous quarterly dividend of 27.0 cents per share, which...
-
OXiGENE Soaring, Up 45% (OXGN)
Friday, May 6, 2011 - 3:36pm | 61OXiGENE, Inc. (NASDAQ: OXGN) shares are soaring today, gaining 45% on more than ten times its average daily volume. At last check shares of OXiGene were up $1.10 to $3.45, a gain of 46% on 5.5 million shares. OXiGENE, Inc., a clinical-stage biopharmaceutical company, engages in developing...
-
Preventing the Most Common Form of Cancer (DUSA)
Friday, May 6, 2011 - 2:23pm | 802Right now, about 58 million Americans suffer from the most common form of skin pre-cancer - Actinic Kerotosis (AK). I say pre-cancer because with the right treatment, this relatively common skin condition can be prevented. But, if not treated properly there is a...
-
Preventing the Most Common Form of Cancer (DUSA)
Friday, May 6, 2011 - 2:23pm | 802Right now, about 58 million Americans suffer from the most common form of skin pre-cancer - Actinic Kerotosis (AK). I say pre-cancer because with the right treatment, this relatively common skin condition can be prevented. But, if not treated properly there is a...